Multiple Endocrine Neoplasia Type 2 (MEN2)
Author:
Hodgson Anjelica,Pakbaz Sara,Mete Ozgur
Publisher
Springer International Publishing
Reference17 articles.
1. Brandi, M. L., Gagel, R. F., Angeli, A., Bilezikian, J. P., Beck-Peccoz, P., Bordi, C., Conte-Devolx, B., Falchetti, A., Gheri, R. G., Libroia, A., Lips, C. J., Lombardi, G., Mannelli, M., Pacini, F., Ponder, B. A., Raue, F., Skogseid, B., Tamburrano, G., Thakker, R. V., Thompson, N. W., Tomassetti, P., Tonelli, F., Wells, S. A., Jr., & Marx, S. J. (2001). Guidelines for diagnosis and therapy for MEN type 1 and type 2. Journal of Clinical Endocrinology and Metabolism, 86, 5658. 2. Castinetti, F., Waguespack, S. G., Machens, A., Uchino, S., Hasse-Lazar, K., Sanso, G., Else, T., Dvorakova, S., Qi, X. P., Elisei, R., Maia, A. L., Glod, J., Lourenco, D. M., Jr., Valdes, N., Mathiesen, J., Wohllk, N., Bandgar, T. R., Drui, D., Korbonits, M., Druce, M. R., Brain, C., Kurzawinski, T., Patocs, A., Bugalho, M. J., Lacroix, A., Caron, P., Fainstein-Day, P., Borson Chazot, F., Klein, M., Links, T. P., Letizia, C., Fugazzola, L., Chabre, O., Canu, L., Cohen, R., Tabarin, A., Spehar Uroic, A., Maiter, D., Laboureau, S., Mian, C., Peczkowska, M., Sebag, F., Brue, T., Mirebeau-Prunier, D., Leclerc, L., Bausch, B., Berdelou, A., Sukurai, A., Vlcek, P., Krajewska, J., Barontini, M., Vaz Ferreira Vargas, C., Valerio, L., Ceolin, L., Akshintala, S., Hoff, A., Godballe, C., Jarzab, B., Jimenez, C., Eng, C., Imai, T., Schlumberger, M., Grubbs, E., Dralle, H., Neumann, H. P., & Baudin, E. (2019). Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: An international, multicentre, retrospective study. The Lancet Diabetes and Endocrinology, 7, 213–220. 3. Costante, G., Durante, C., Francis, Z., Schlumberger, M., & Filetti, S. (2009). Determination of calcitonin levels in C-cell disease: Clinical interest and potential pitfalls. Nature Clinical Practice Endocrinology and Metabolism, 5, 35–44. 4. Duan, K., & Mete, O. (2017). Hereditary endocrine tumor syndromes: The clinical and predictive role of molecular histopathology. AJSP: Reviews & Reports, 22, 246–268. 5. Elisei, R., Romei, C., Cosci, B., Agate, L., Bottici, V., Molinaro, E., Sculli, M., Miccoli, P., Basolo, F., Grasso, L., Pacini, F., & Pinchera, A. (2007). RET genetic screening in patients with medullary thyroid cancer and their relatives: Experience with 807 individuals at one center. Journal of Clinical Endocrinology and Metabolism, 92, 4725–4729.
|
|